Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00268164|
Recruitment Status : Terminated (Inclusion was difficult and to slow)
First Posted : December 22, 2005
Last Update Posted : May 6, 2015
|Condition or disease||Intervention/treatment||Phase|
|Ulcerative Colitis||Drug: lactobacilus acidophilus & bifidobacterium animalis/lactis||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||48 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis|
|Study Start Date :||June 2004|
|Primary Completion Date :||March 2007|
|Study Completion Date :||March 2007|
- Number of patients with relapse at 12 month.
- Number of days to relapse.
- Presence and concentrations of the probiotic bacterial strains in stool.
- Safety and tolerance of the probiotic mixture.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00268164
|Dept. of Medical Gastroenterology|
|Hvidovre, Denmark, 2650|
|Study Chair:||Flemming Bendtsen, MD, DMSci||Dept. of Medical Gastroenterology, Hvidovre University Hospital, Denmark|